Article Information
History
- April 27, 2022.
Article Versions
- You are currently viewing Version 1 of this article (April 27, 2022 - 16:01).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Barbara Barth, MSc1,2,3,
- Danusa Arcego Mar, PhD2,3,
- Euclides José de Mendonça Filho, PhD2,3,
- Randriely Merscher Sobreira de Lima, MSc4,
- Sachin Patel2,3,
- Omar Khedr2,3,
- Zihan Wang, MSc2,3,
- Carine Parent, PhD2,3,
- Carla Dalmaz, PhD4,
- André Krumel Portella, MD, PhD2,3,
- Irina Pokhvisneva, MSc2,3,
- Michael J Meaney, PhD, CQ, FRSC2,3,5,6 and
- Patricia Pelufo Silveira, MD, PhD2,3,5,*
- 1Integrated Program in Neurosciences, McGill University, Montreal, QC, Canada
- 2Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada
- 3Ludmer Centre for Neuroinformatics and Mental Health, Douglas Research Centre, McGill University, Montreal, QC, Canada
- 4Programa de Pós-Graduação em Neurociências, Instituto de Ciências Básicas da Saúde (ICBS), Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
- 5Department of Psychiatry, Faculty of Medicine, McGill University, Montreal, QC, Canada
- 6Translational Neuroscience Programme, Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore
- ↵*Corresponding author: Patricia Pelufo Silveira, MD, PhD, Department of Psychiatry, Faculty of Medicine, McGill University, Douglas Research Centre, 6875 Boulevard LaSalle, Montreal, QC, H4H 1R3, Canada. Phone: 514-761-6131 (ext.2776), Fax: 514-761-6131, patricia.silveira{at}mcgill.ca
Posted April 27, 2022.
A mesocorticolimbic dopamine gene network moderates the effect of early adversity on the risk for psychiatric and cardio-metabolic comorbidities
